Annual Report 2017

April 16, 2018

What to Expect from This Document?

Better known up until a few years ago for its bioseparation and enabling of
manufacturing of biopharmaceuticals expertise, Prometic has during 2017, continued
its transition that has transformed the company into a biopharmaceutical
corporation with two drug discovery platforms focusing on rare and orphan
diseases representing significant and unmet medical needs.

No Previous Flipbooks

Next Flipbook
Annual Information Form 2017
Annual Information Form 2017

Prometic Annual Information Form 2017